miR-139-5p Is a Regulator of Metastatic Pathways in Breast Cancer

RNA - United States
doi 10.1261/rna.042143.113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Expression and Clinical Significance of miR-139-5p in Non-Small Cell Lung Cancer

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

MiR-483-5p and miR-139-5p Promote Aggressiveness by Targeting N-Myc Downstream-Regulated Gene Family Members in Adrenocortical Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Overexpression of Circulating MiR-30b-5p Identifies Advanced Breast Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

miR-195 Is a Key Regulator of Raf1 in Thyroid Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2019English

Stepwise Analysis of MIR9 Loci Identifies miR-9-5p to Be Involved in Oestrogen Regulated Pathways in Breast Cancer Patients

Scientific Reports
Multidisciplinary
2017English

The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis

International Journal of Oncology
Cancer ResearchOncology
2014English

Myoferlin Is a Key Regulator of EGFR Activity in Breast Cancer

Cancer Research
Cancer ResearchOncology
2013English

Figure 6: Quantitative PCR Analysis of miR-26a-5p, miR-181a-5p, miR-34a-5p, miR-93-5p, Pten, Creb, BCL-2, and Sirt1 Expression in miR-26a-5p (A), miR-181a-5p (B), miR-34a-5p (C), miR-93-5p (D) Mimic Transfected HUVECs.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy